Peringatan Keamanan

The most common adverse events reported in clinical trials were ankle oedema (6%), headache (3.8%), palpitation (2.7%), flushing (2.2%), dizziness (1.6%), rash (0.5%) and fatigue (0.5%) A7845.

Manidipine

DB09238

small molecule approved investigational

Deskripsi

Manidipine (INN) is a calcium channel blocker (dihydropyridine type) that is used clinically as an antihypertensive. It is selective for vasculature and does not produce effects on the heart at clinically relevant dosages.

Struktur Molekul 2D

Berat 610.711
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) The half life of elimination has been observed to be dose dependent [A7845]. Doses of 5, 10, and 20 mg produced half lives of 3.94, 5.02, and 7.95 h respectively.
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

The median Tmax is 1.5 h A7845. Administration with food produces an 1.3-1.6-fold increase in Cmax but no change in Tmax. Manidipine does not accumulate significantly with multiple doses.

Metabolisme

Manidipine is extensively metabolized by CYP enzymes to pyridine derivatives and diphenylmethane derivatives which make up 4-7% and 22-24% of the dose excreted in the urine A7845.

Rute Eliminasi

Manidipine is eliminated through extensive metabolism. 63% is eliminated in the feces and 31% in the urine as metabolites A7845.

Interaksi Obat

1401 Data
Lomitapide The metabolism of Lomitapide can be decreased when combined with Manidipine.
Ceritinib Manidipine may increase the bradycardic activities of Ceritinib.
Ivabradine Manidipine may increase the bradycardic activities of Ivabradine.
Ruxolitinib Ruxolitinib may increase the bradycardic activities of Manidipine.
Cilostazol The serum concentration of Cilostazol can be increased when it is combined with Manidipine.
Amifostine Manidipine may increase the hypotensive activities of Amifostine.
Diazoxide Diazoxide may increase the hypotensive activities of Manidipine.
Methylphenidate Methylphenidate may decrease the antihypertensive activities of Manidipine.
Dexmethylphenidate Dexmethylphenidate may decrease the antihypertensive activities of Manidipine.
Obinutuzumab Manidipine may increase the hypotensive activities of Obinutuzumab.
Pentoxifylline Pentoxifylline may increase the hypotensive activities of Manidipine.
Rituximab Manidipine may increase the hypotensive activities of Rituximab.
Desmopressin Desmopressin may decrease the antihypertensive activities of Manidipine.
Isoetharine Isoetharine may decrease the antihypertensive activities of Manidipine.
Etomidate Etomidate may decrease the antihypertensive activities of Manidipine.
Zolmitriptan Zolmitriptan may decrease the antihypertensive activities of Manidipine.
Norepinephrine Norepinephrine may decrease the antihypertensive activities of Manidipine.
Phenylpropanolamine Phenylpropanolamine may decrease the antihypertensive activities of Manidipine.
Doxapram Doxapram may decrease the antihypertensive activities of Manidipine.
Metaraminol Metaraminol may decrease the antihypertensive activities of Manidipine.
Sumatriptan Sumatriptan may decrease the antihypertensive activities of Manidipine.
Methoxamine Methoxamine may decrease the antihypertensive activities of Manidipine.
Orciprenaline Orciprenaline may decrease the antihypertensive activities of Manidipine.
Phenmetrazine Phenmetrazine may decrease the antihypertensive activities of Manidipine.
Dobutamine Dobutamine may decrease the antihypertensive activities of Manidipine.
Pseudoephedrine Pseudoephedrine may decrease the antihypertensive activities of Manidipine.
Ritodrine Ritodrine may decrease the antihypertensive activities of Manidipine.
Terbutaline Terbutaline may decrease the antihypertensive activities of Manidipine.
Bitolterol Bitolterol may decrease the antihypertensive activities of Manidipine.
Diethylpropion Diethylpropion may decrease the antihypertensive activities of Manidipine.
Naratriptan Naratriptan may decrease the antihypertensive activities of Manidipine.
Rizatriptan Rizatriptan may decrease the antihypertensive activities of Manidipine.
Dopamine Dopamine may decrease the antihypertensive activities of Manidipine.
Frovatriptan Frovatriptan may decrease the antihypertensive activities of Manidipine.
Isoprenaline Isoprenaline may decrease the antihypertensive activities of Manidipine.
Arbutamine Arbutamine may decrease the antihypertensive activities of Manidipine.
Fenoterol Fenoterol may decrease the antihypertensive activities of Manidipine.
Pirbuterol Pirbuterol may decrease the antihypertensive activities of Manidipine.
Ephedra sinica root Ephedra sinica root may decrease the antihypertensive activities of Manidipine.
Ephedrine Ephedrine may decrease the antihypertensive activities of Manidipine.
Mephentermine Mephentermine may decrease the antihypertensive activities of Manidipine.
Procaterol Procaterol may decrease the antihypertensive activities of Manidipine.
Clenbuterol Clenbuterol may decrease the antihypertensive activities of Manidipine.
Bambuterol Bambuterol may decrease the antihypertensive activities of Manidipine.
MMDA MMDA may decrease the antihypertensive activities of Manidipine.
2,5-Dimethoxy-4-ethylamphetamine 2,5-Dimethoxy-4-ethylamphetamine may decrease the antihypertensive activities of Manidipine.
4-Bromo-2,5-dimethoxyamphetamine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Manidipine.
Tenamfetamine Tenamfetamine may decrease the antihypertensive activities of Manidipine.
Chlorphentermine Chlorphentermine may decrease the antihypertensive activities of Manidipine.
Phendimetrazine Phendimetrazine may decrease the antihypertensive activities of Manidipine.
Epicaptopril Epicaptopril may decrease the antihypertensive activities of Manidipine.
1-benzylimidazole 1-benzylimidazole may decrease the antihypertensive activities of Manidipine.
Amineptine Amineptine may decrease the antihypertensive activities of Manidipine.
Amibegron Amibegron may decrease the antihypertensive activities of Manidipine.
Naluzotan Naluzotan may decrease the antihypertensive activities of Manidipine.
Solabegron Solabegron may decrease the antihypertensive activities of Manidipine.
Droxidopa Droxidopa may decrease the antihypertensive activities of Manidipine.
Nitrous oxide Nitrous oxide may decrease the antihypertensive activities of Manidipine.
Isometheptene Isometheptene may decrease the antihypertensive activities of Manidipine.
Levonordefrin Levonordefrin may decrease the antihypertensive activities of Manidipine.
Naphazoline Naphazoline may decrease the antihypertensive activities of Manidipine.
Tetryzoline Tetryzoline may decrease the antihypertensive activities of Manidipine.
Cinitapride Cinitapride may decrease the antihypertensive activities of Manidipine.
Tyramine Tyramine may decrease the antihypertensive activities of Manidipine.
Adrafinil Adrafinil may decrease the antihypertensive activities of Manidipine.
Ifenprodil Ifenprodil may decrease the antihypertensive activities of Manidipine.
Hexoprenaline Hexoprenaline may decrease the antihypertensive activities of Manidipine.
Etilefrine Etilefrine may decrease the antihypertensive activities of Manidipine.
Dimetacrine Dimetacrine may decrease the antihypertensive activities of Manidipine.
Butriptyline Butriptyline may decrease the antihypertensive activities of Manidipine.
Cirazoline Cirazoline may decrease the antihypertensive activities of Manidipine.
Synephrine Synephrine may decrease the antihypertensive activities of Manidipine.
Moxisylyte Moxisylyte may decrease the antihypertensive activities of Manidipine.
Oxaprotiline Oxaprotiline may decrease the antihypertensive activities of Manidipine.
Iofetamine I-123 Iofetamine I-123 may decrease the antihypertensive activities of Manidipine.
Racepinephrine Racepinephrine may decrease the antihypertensive activities of Manidipine.
DL-Methylephedrine DL-Methylephedrine may decrease the antihypertensive activities of Manidipine.
Amitraz Amitraz may decrease the antihypertensive activities of Manidipine.
Medetomidine Medetomidine may decrease the antihypertensive activities of Manidipine.
Xylazine Xylazine may decrease the antihypertensive activities of Manidipine.
Atipamezole Atipamezole may decrease the antihypertensive activities of Manidipine.
Ractopamine Ractopamine may decrease the antihypertensive activities of Manidipine.
Romifidine Romifidine may decrease the antihypertensive activities of Manidipine.
Detomidine Detomidine may decrease the antihypertensive activities of Manidipine.
Etafedrine Etafedrine may decrease the antihypertensive activities of Manidipine.
Tetrahydrocannabivarin Tetrahydrocannabivarin may decrease the antihypertensive activities of Manidipine.
PF-00610355 PF-00610355 may decrease the antihypertensive activities of Manidipine.
Ritobegron Ritobegron may decrease the antihypertensive activities of Manidipine.
Abediterol Abediterol may decrease the antihypertensive activities of Manidipine.
Tulobuterol Tulobuterol may decrease the antihypertensive activities of Manidipine.
Dopexamine Dopexamine may decrease the antihypertensive activities of Manidipine.
Piclozotan Piclozotan may decrease the antihypertensive activities of Manidipine.
Idazoxan Idazoxan may decrease the antihypertensive activities of Manidipine.
Higenamine Higenamine may decrease the antihypertensive activities of Manidipine.
Reproterol Reproterol may decrease the antihypertensive activities of Manidipine.
Theodrenaline Theodrenaline may decrease the antihypertensive activities of Manidipine.
Tramazoline Tramazoline may decrease the antihypertensive activities of Manidipine.
Mephedrone Mephedrone may decrease the antihypertensive activities of Manidipine.
Amitriptylinoxide Amitriptylinoxide may decrease the antihypertensive activities of Manidipine.
Dibenzepin Dibenzepin may decrease the antihypertensive activities of Manidipine.

Target Protein

Voltage-dependent L-type calcium channel CACNA1C
Voltage-dependent L-type calcium channel subunit alpha-1C CACNA1C
Cruzipain
Voltage-dependent L-type calcium channel subunit alpha-1D CACNA1D
Voltage-dependent T-type calcium channel CACNA1G
Voltage-dependent T-type calcium channel subunit alpha-1G CACNA1G
Voltage-dependent T-type calcium channel subunit alpha-1H CACNA1H
Voltage-dependent T-type calcium channel subunit alpha-1I CACNA1I

Referensi & Sumber

Artikel (PubMed)
  • PMID: 11693466
    Cheer SM, McClellan K: Manidipine: a review of its use in hypertension. Drugs. 2001;61(12):1777-99.
  • PMID: 15329044
    McKeage K, Scott LJ: Manidipine: a review of its use in the management of hypertension. Drugs. 2004;64(17):1923-40.

Contoh Produk & Brand

Produk: 0 • International brands: 1
International Brands
  • Manyper

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul